GSK plc (GSK)

GSK Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	6,289	2,951	5,308	4,921	3,516
Depreciation & Amortization	2,314	2,551	2,294	2,147	2,122
Stock-Based Compensation	374	344	307	346	343
Other Adjustments	2,742	1,270	1,785	1,488	745
Change in Receivables	-1,097	340	-649	-616	-1,162
Changes in Inventories	-140	-294	-424	-269	51
Changes in Accounts Payable	131	-179	-15	494	229
Changes in Income Taxes Payable	-1,202	-1,307	-1,328	-1,310	-972
Changes in Other Operating Activities	-1,670	878	-510	971	4,755
Operating Cash Flow	7,741	6,554	6,768	7,403	7,952
Operating Cash Flow Growth	18.11%	-3.16%	-8.58%	-6.90%	-5.79%
Capital Expenditures	-1,348	-1,399	-1,314	-1,143	-950
Sale of Property, Plant & Equipment	24	65	28	146	132
Purchases of Intangible Assets	-1,637	-1,583	-1,030	-1,115	-1,704
Proceeds from Sale of Intangible Assets	115	131	12	196	641
Purchases of Investments	-92	-146	-123	-144	-163
Proceeds from Sale of Investments	189	2,356	1,833	238	479
Payments for Business Acquisitions	-1,692	-805	-1,457	-3,108	-
Proceeds from Business Divestments	-27	-18	49	-43	-17
Other Investing Activities	235	170	407	-3,799	-195
Investing Cash Flow	-4,233	-1,229	-1,595	-8,772	-1,777
Short-Term Debt Issued	1,215	-545	-333	1,021	301
Short-Term Debt Repaid	-288	-81	-	-	-2,304
Net Short-Term Debt Issued (Repaid)	927	-626	-333	1,021	-2,003
Long-Term Debt Issued	579	-540	-2,037	-5,643	-
Net Long-Term Debt Issued (Repaid)	579	-540	-2,037	-5,643	-
Issuance of Common Stock	15	20	10	25	21
Repurchase of Common Stock	-1,377	-	-	-	-
Net Common Stock Issued (Repurchased)	-1,362	20	10	25	21
Common Dividends Paid	-2,564	-2,444	-2,247	-3,467	-3,999
Other Financing Activities	-1,265	-1,136	-1,034	8,887	-1,608
Financing Cash Flow	-3,685	-4,726	-5,641	823	-7,589
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-19	-54	-99	152	-29
Net Cash Flow	-177	599	-468	-546	-1,414
Free Cash Flow	6,393	5,155	5,454	6,260	7,002
Free Cash Flow Growth	24.02%	-5.48%	-12.88%	-10.60%	-6.04%
FCF Margin	19.57%	16.43%	17.98%	21.35%	28.35%
Free Cash Flow Per Share	3.11	2.49	2.65	3.07	3.46
Levered Free Cash Flow	5,307	1,659	1,261	11,224	7,617
Unlevered Free Cash Flow	4,825	3,663	4,607	6,515	9,492

Updated Feb 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q